Literature DB >> 24068455

Reversible pituitary insufficiency due to bexarotene therapy in a patient with mycosis fungoides.

Hulusi Atmaca1, Ismail Islek, Nilgün Sentürk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24068455     DOI： 10.1007/s11102-013-0523-z

Source DB:  PubMed          Journal:  Pituitary        ISSN： 1386-341X            Impact factor:   4.107


× No keyword cloud information.
  3 in total

1.  Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects.

Authors:  Wendy M Golden; Katie B Weber; Teri L Hernandez; Steven I Sherman; Whitney W Woodmansee; Bryan R Haugen
Journal:  J Clin Endocrinol Metab       Date:  2006-10-24       Impact factor: 5.958

Review 2.  Drugs that suppress TSH or cause central hypothyroidism.

Authors:  Bryan R Haugen
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-12       Impact factor: 4.690

3.  Granulomatous adenohypophysitis after interferon and ribavirin therapy.

Authors:  Peter J Tebben; John L D Atkinson; Bernd W Scheithauer; Dana Erickson
Journal:  Endocr Pract       Date:  2007 Mar-Apr       Impact factor: 3.443
  3 in total
  1 in total

1.  Targeting the TR4 nuclear receptor with antagonist bexarotene can suppress the proopiomelanocortin signalling in AtT-20 cells.

Authors:  Liqun Xia; Danyang Shen; Youyun Zhang; Jieyang Lu; Mingchao Wang; Huan Wang; Yuanlei Chen; Dingwei Xue; Dajiang Xie; Gonghui Li
Journal:  J Cell Mol Med       Date:  2021-01-24       Impact factor: 5.310
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.